IOBT
IO Biotech Inc
NASDAQ: IOBT · HEALTHCARE · BIOTECHNOLOGY
$0.05
+0.00% today
Updated 2026-04-07
Market cap
$2.32M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.34
Dividend yield
—
52W range
$0 – $3
Volume
14.5M
IO Biotech Inc (IOBT) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-240.50%
ROA
-88.60%
Debt/equity
1.60x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | $0.00 | $-10.75M | — | — | — |
| 2020 | $0.00 | $-12.04M | — | — | — |
| 2021 | $0.00 | $-67.88M | — | — | — |
| 2022 | $0.00 | $-71.46M | — | — | — |
| 2023 | $0.00 | $-86.08M | — | — | — |
| 2024 | $0.00 | $-95.49M | — | — | — |